Lada LeyensSenior Director - Regulatory Clinical Trial Innovation and Digital Health at Roche, Switzerland
Agenda Sessions
PANEL: Looking into the Clinical Future: What Will Stay Post Pandemic?
, 16:50View SessionChairperson Opening Comments
, 08:50View SessionUsing Digital Health Technologies to Measure Meaningful Endpoints: Validation and Regulatory Considerations
, 12:10View Session